您的位置: 首页 > 农业专利 > 详情页

Methods for the treatment of overweight and obesity
专利权人:
INC.;OREXIGEN THERAPEUTICS
发明人:
PRESTON KLASSEN,KRISTIN TAYLOR
申请号:
ARP130104443
公开号:
AR093694A1
申请日:
2013.12.02
申请国别(地区):
AR
年份:
2015
代理人:
摘要:
This note refers to the ingredients, toolkits, uses, systems and methods for dealing with overweight and obesity, preferably a comprehensive weight control program combined with Internet and / or telephone management, preferably for people at risk. What's more serious is heart disease 1. Requirement 1: a method for treating patients most likely to suffer adverse cardiovascular consequences, characterized by:2. Overweight or obese: identify a obese or overweight patient who is most likely to suffer from adverse cardiovascular disease; And the main body of the effective treatment, so that it has sustained release of Nadine or a drug acceptable salts and sustained release of propyl bromide, or a drug acceptable salts. Claim 2: Method in accordance with claim 1,It is characterized by the fact that people who are considered overweight or obese (a) are most likely to suffer from adverse cardiovascular consequences if they are diagnosed with cardiovascular disease with at least one risk factor, Selected from the following groups: recorded myocardial infarction records, more than 3 months before confirmation; history of coronary retransplantation, including coronary artery transplantation; stent placement, Traumatic coronary angioplasty or laser capsulectomy; history of expensive or marginal chemotherapy,Even if it is hypertension, endocrinology, lower extremity myocardial obstruction resection, abdominal aneurysm repair, negative or epidemic myocardial infarction, ischemic vascular changes, ECG changes for skilled gymnastics test or just like heart research; Brain index of ankle and lt; 0.9% estimated by simple physical contact in the first two years of ankle and lt determination; and 50% of coronary, carotid or inferior arteries in the first two years of ankle, carotid or lower extremity determination; And / or (b) have a diagnosis of type 2 diabetes with at least 2 risk factors,Selected from the following groups: hypertension with or without pharmacological treatment; 14
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充